Morgan Stanley’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,074
Closed 6775
2016
Q2
$0 Buy
1,074
+841
+361% +$1.35K ﹤0.01% 7007
2016
Q1
$1K Buy
233
+83
+55% +$233 ﹤0.01% 6536
2015
Q4
$0 Sell
150
-1,500
-91% -$6.76K ﹤0.01% 7121
2015
Q3
$7K Sell
1,650
-166
-9% -$975 ﹤0.01% 6344
2015
Q2
$11K Sell
1,816
-2,512
-58% -$17.1K ﹤0.01% 6290
2015
Q1
$38K Buy
4,328
+545
+14% +$4.38K ﹤0.01% 5890
2014
Q4
$22K Buy
3,783
+2,770
+273% +$14.5K ﹤0.01% 6031
2014
Q3
$7K Buy
+1,013
New +$8.76K ﹤0.01% 6288

Other funds holding EPRS